SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-347821
Filing Date
2012-08-09
Accepted
2012-08-09 16:55:07
Documents
12
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d364467d10q.htm 10-Q 687600
2 EX-10.1 d364467dex101.htm EX-10.1 749065
3 EX-31.1 d364467dex311.htm EX-31.1 8978
4 EX-31.2 d364467dex312.htm EX-31.2 9018
5 EX-32.1 d364467dex321.htm EX-32.1 4932
12 GRAPHIC g364467g11d05.jpg GRAPHIC 7676
  Complete submission text file 0001193125-12-347821.txt   5563796

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arna-20120630.xml EX-101.INS 584943
7 XBRL TAXONOMY EXTENSION SCHEMA arna-20120630.xsd EX-101.SCH 53047
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arna-20120630_cal.xml EX-101.CAL 56915
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arna-20120630_def.xml EX-101.DEF 239561
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20120630_lab.xml EX-101.LAB 366036
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20120630_pre.xml EX-101.PRE 286974
Mailing Address 6166 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6166 NANCY RIDGE DR SAN DIEGO CA 92121 8584537200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31161 | Film No.: 121021072
SIC: 2834 Pharmaceutical Preparations